Linked Life Data

10910225

Source:http://linkedlifedata.com/resource/pubmed/id/10910225

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2000-12-28
pubmed:abstractText
The purpose of the present study was to evaluate the antitumor activity and toxicity of oral estramustine phosphate (EMP) in combination with oral etoposide in patients with hormone-refractory prostate cancer.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
0919-8172
pubmed:author
pubmed:issnType
Print
pubmed:volume
7
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
243-7
pubmed:dateRevised
2006-10-30
pubmed:meshHeading
pubmed:year
2000
pubmed:articleTitle
Oral estramustine phosphate and oral etoposide for the treatment of hormone-refractory prostate cancer.
pubmed:affiliation
Department of Urology, National Shikoku Cancer Center Hospital, Matsuyama, Ehime, Japan. ysumiyos@shikoku-cc.go.jp
pubmed:publicationType
Journal Article, Clinical Trial